Literature DB >> 16557517

Survivin study: an update of "what is the next wave"?

Fengzhi Li1, Xiang Ling.   

Abstract

Studies on survivin over the past 2-3 years have shown that survivin possesses multiple subcellular localizations and is a multifunctional molecule involved in many aspects of cellular processes and/or behaviors. The subcellular localization and function of the survivin splice variants, however, have not yet been well elucidated. We have, therefore, provided additional observations on several survivin splice variants for further exploration. This review article will update the role of survivin, and its splice variants in the mitosis/cell cycle, apoptosis, tumorigenesis, chemoprevention, drug/radiation resistance, and cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16557517      PMCID: PMC2821201          DOI: 10.1002/jcp.20634

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  68 in total

1.  Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.

Authors:  Kazuhiro Kami; Ryuichiro Doi; Masayuki Koizumi; Eiji Toyoda; Tomohiko Mori; Daisuke Ito; Yoshiya Kawaguchi; Koji Fujimoto; Michihiko Wada; Shin-Ichi Miyatake; Masayuki Imamura
Journal:  Surgery       Date:  2005-08       Impact factor: 3.982

2.  Chromosome alignment and segregation regulated by ubiquitination of survivin.

Authors:  Queenie P Vong; Kan Cao; Hoi Y Li; Pablo A Iglesias; Yixian Zheng
Journal:  Science       Date:  2005-12-02       Impact factor: 47.728

3.  Molecular cloning and bioinformatics analysis of a novel spliced variant of survivin from human breast cancer cells.

Authors:  Wenyun Zheng; Xingyuan Ma; Dongzhi Wei; Tianwen Wang; Yushu Ma; Shengli Yang
Journal:  DNA Seq       Date:  2005-10

4.  Cell biology. Keeping survivin nimble at centromeres in mitosis.

Authors:  William C Earnshaw
Journal:  Science       Date:  2005-12-02       Impact factor: 47.728

Review 5.  Role of the Survivin gene in pathophysiology.

Authors:  Fengzhi Li; Michael G Brattain
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

6.  Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis.

Authors:  S Fukuda; L M Pelus
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

7.  Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin.

Authors:  Hsei-Wei Wang; Tyson V Sharp; Andrew Koumi; Georgy Koentges; Chris Boshoff
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

8.  Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation.

Authors:  Larisa L Belyanskaya; Sally Hopkins-Donaldson; Stefanie Kurtz; Ana Paula Simões-Wüst; Shida Yousefi; Hans-Uwe Simon; Rolf Stahel; Uwe Zangemeister-Wittke
Journal:  Int J Cancer       Date:  2005-12-10       Impact factor: 7.396

9.  Survivin mediates targeting of the chromosomal passenger complex to the centromere and midbody.

Authors:  Gerben Vader; Jos J W Kauw; René H Medema; Susanne M A Lens
Journal:  EMBO Rep       Date:  2006-01       Impact factor: 8.807

10.  Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis.

Authors:  Elizabeth A Noton; Rita Colnaghi; Sharon Tate; Carlene Starck; Ana Carvalho; Paul Ko Ferrigno; Sally P Wheatley
Journal:  J Biol Chem       Date:  2005-11-16       Impact factor: 5.157

View more
  69 in total

Review 1.  Progress of molecular targeted therapies for prostate cancers.

Authors:  Weihua Fu; Elena Madan; Marla Yee; Hongtao Zhang
Journal:  Biochim Biophys Acta       Date:  2011-11-29

2.  Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter.

Authors:  Qiuying Cheng; Xiang Ling; Andrew Haller; Takahito Nakahara; Kentaro Yamanaka; Aya Kita; Hiroshi Koutoku; Masahiro Takeuchi; Michael G Brattain; Fengzhi Li
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

Review 3.  Role of the Survivin gene in pathophysiology.

Authors:  Fengzhi Li; Michael G Brattain
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

4.  High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer.

Authors:  O P Erpolat; P U Gocun; M Akmansu; E Karakus; G Akyol
Journal:  Strahlenther Onkol       Date:  2012-02-08       Impact factor: 3.621

5.  Up-regulation of survivin by the E2A-HLF chimera is indispensable for the survival of t(17;19)-positive leukemia cells.

Authors:  Mayuko Okuya; Hidemitsu Kurosawa; Jiro Kikuchi; Yusuke Furukawa; Hirotaka Matsui; Daisuke Aki; Takayuki Matsunaga; Takeshi Inukai; Hiroaki Goto; Rachel A Altura; Kenich Sugita; Osamu Arisaka; A Thomas Look; Toshiya Inaba
Journal:  J Biol Chem       Date:  2009-11-02       Impact factor: 5.157

6.  Sanguinarine suppresses prostate tumor growth and inhibits survivin expression.

Authors:  Meng Sun; Wei Lou; Jae Yeon Chun; Daniel S Cho; Nagalakshmi Nadiminty; Christopher P Evans; Jun Chen; Jiao Yue; Qinghua Zhou; Allen C Gao
Journal:  Genes Cancer       Date:  2010-03

7.  FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties.

Authors:  Jin Wang; Zhantao Liu; Dandan Zhang; Ranran Liu; Qian Lin; Jia Liu; Zhihong Yang; Qingxia Ma; Dantong Sun; Xin Zhou; Guohui Jiang
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

8.  Association of cigarette smoking with the expression of nuclear survivin in pathological Stage IA lung adenocarcinomas.

Authors:  Hiroshi Hirano; Hajime Maeda; Yukiyasu Takeuchi; Yoshiyuki Susaki; Ryoji Kobayashi; Akio Hayashi; Naoko Ose; Yukie Nakazawa; Toshihiko Yamaguchi; Soichiro Yokota; Masahide Mori
Journal:  Med Mol Morphol       Date:  2013-11-09       Impact factor: 2.309

9.  Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter.

Authors:  Jae Yeon Chun; Yan Hu; Elaine Pinder; Jianguo Wu; Fengzhi Li; Allen C Gao
Journal:  Mol Cancer Ther       Date:  2007-09       Impact factor: 6.261

10.  Enhancing effectiveness of the MDR-sensitive compound T138067 using advanced treatment with negative modulators of the drug-resistant protein survivin.

Authors:  Xiang Ling; Xiang He; Pasha Apontes; Felicia Cao; Rami G Azrak; Fengzhi Li
Journal:  Am J Transl Res       Date:  2009-07-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.